Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Stem Cell Procurement

Hypercholesterolemia and its association with enhanced stem cell mobilization and harvest after high-dose cyclophosphamide+G-CSF

Subjects

Abstract

High-dose chemotherapy with autologous peripheral blood SCT is a common treatment option in several hematological and non-hematological malignancies. So far, prediction of successful stem cell mobilization and harvest is limited. Just recently, hypercholesterolemia was shown to increase mobilization of hematopoietic progenitor cells into the peripheral circulation in mice. On the basis of these results, we performed a retrospective multivariate analysis incorporating a variety of clinical parameters in 83 patients following high-dose cyclophosphamide+G-CSF treatment. Interestingly, we found a significant positive correlation between stem cell mobilization and harvest for plasma cholesterol and lactate dehydrogenase (LDH) only. Patients with hypercholesterolemia showed a substantially higher median peripheral blood CD34+-peak (126 vs 47/μL, P=0.003), higher median number of harvested CD34+-cells/kg (9.6 vs 7.4 × 106/kg, P<0.001) and a sufficient number for at least one SCT in a remarkably higher proportion (84.9 vs 52.9%, P=0.003) compared with patients with normal cholesterol levels.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841–846.

    Article  CAS  PubMed  Google Scholar 

  2. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836–841.

    Article  CAS  PubMed  Google Scholar 

  3. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149–161.

    Article  CAS  PubMed  Google Scholar 

  4. Goodman JW, Hodgson GS . Evidence for stem cells in the peripheral blood of mice. Blood 1962; 19: 702–714.

    CAS  PubMed  Google Scholar 

  5. Mendez-Ferrer S, Frenette PS . Hematopoietic stem cell trafficking: regulated adhesion and attraction to bone marrow microenvironment. Ann NY Acad Sci 2007; 1116: 392–413.

    Article  CAS  PubMed  Google Scholar 

  6. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS . Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008; 452: 442–447.

    Article  CAS  PubMed  Google Scholar 

  7. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL . Physiological migration of hematopoietic stem and progenitor cells. Science 2001; 294: 1933–1936.

    Article  CAS  PubMed  Google Scholar 

  8. Abkowitz JL, Robinson AE, Kale S, Long MW, Chen J . Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood 2003; 102: 1249–1253.

    Article  CAS  PubMed  Google Scholar 

  9. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3: 687–694.

    Article  CAS  PubMed  Google Scholar 

  10. Fu S, Liesveld J . Mobilization of hematopoietic stem cells. Blood Rev 2000; 14: 205–218.

    Article  CAS  PubMed  Google Scholar 

  11. Morgan SJ, Seymour JF, Grigg A, Matthews JP, Prince HM, Wolf MM et al. Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine. Leukemia 2004; 18: 1034–1038.

    Article  CAS  PubMed  Google Scholar 

  12. Gertz MA . Current status of stem cell mobilization. Br J Haematol 2010; 150: 647–662.

    Article  CAS  PubMed  Google Scholar 

  13. Gomes AL, Carvalho T, Serpa J, Torre C, Dias S . Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis. Blood 2010; 115: 3886–3894.

    Article  CAS  PubMed  Google Scholar 

  14. Egan K, Singh V, Gidron A, Mehta J . Correlation between serum lactate dehydrogenase and stem cell mobilization. Bone Marrow Transplant 2007; 40: 931–934.

    Article  CAS  PubMed  Google Scholar 

  15. Langsted A, Freiberg JJ, Nordestgaard BG . Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008; 118: 2047–2056.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Wilop.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crysandt, M., Hilgers, RD., Hobe, S. et al. Hypercholesterolemia and its association with enhanced stem cell mobilization and harvest after high-dose cyclophosphamide+G-CSF. Bone Marrow Transplant 46, 1426–1429 (2011). https://doi.org/10.1038/bmt.2010.327

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2010.327

Keywords

This article is cited by

Search

Quick links